The incidence of cough during treatment with angiotensin converting enzyme inhibitors.
The incidence of cough during treatment with angiotensin converting enzyme (ACE) inhibitors was studied using retrospective analysis of outpatient records and a questionnaire; for a more precise evaluation, all reported cases of cough were reviewed according to criteria for the operational assessment of side effects, and those found unrelated were excluded. Cough during treatment with ACE inhibitors appears to be more frequent than previously recorded and substantial differences between patients treated with captopril or enalapril seem unlikely.
Strocchi
E
E
Cattedra di Terapia Medica Sistematica, Università di Bologna, Italy.
Valtancoli
G
G
Ambrosioni
E
E
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D002216:Captopril / Q000009:adverse effects; D003371:Cough / Q000139:chemically induced* / Q000453:epidemiology; D004656:Enalapril / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D015994:Incidence; D007558:Italy / Q000453:epidemiology; D012737:Sex Factors; D011795:Surveys and Questionnaires
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D002216:Captopril